NYXH

Nyxoah

NYXH, USA

Nyxoah SA, a medical technology company, develops and commercializes solutions to treat obstructive sleep apnea (OSA). The company's lead solution comprises Genio system, a CE-Marked, patient-centric, minimally invasive, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah SA was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

https://www.nyxoah.com

Stock Price

$ 0.00

0% decrease compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
NYXH
stock
NYXH

Nyxoah (NASDAQ:NYXH) Trading Down 2.9% – Here’s What Happened Defense World

Read more →
NYXH
stock
NYXH

Nyxoah (ENXTBR:NYXH) Price Target Decreased by 17.36% to 10.07 Nasdaq

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

BUY

Target Price:

$11.2503

Analyst Picks

Strong Buy

3

Buy

1

Hold

1

Sell

0

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Book Ratio (P/B)

-

Very High

3.47

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

-46.28 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

-25.19 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very Low

-1,039.96 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Low

0.84

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 8.19% of the total shares of Nyxoah

1.

Fidelity Small Cap Growth

(1.2056%)

since

2025/06/30

2.

BNP Paribas B Pension Bal Classic

(1.1313%)

since

2025/07/31

3.

BlackRock Health Sciences Opps Inv A

(1.0463%)

since

2025/07/31

4.

APO Medical Opportunities R

(0.9056%)

since

2025/07/31

5.

BlackRock Health Sciences Term Trust

(0.6773%)

since

2025/06/30

6.

Fidelity Small Cap Growth K6

(0.6044%)

since

2025/06/30

7.

Swedbank Robur Healthcare A

(0.4395%)

since

2025/07/31

8.

Belfius Equities Bel=Go C Cap

(0.4112%)

since

2025/06/30

9.

BNP Paribas Belgium Equity Cl EUR Acc

(0.3551%)

since

2025/04/30

10.

Mandarine Europe Microcap R EUR

(0.3409%)

since

2025/05/31

11.

BNP Paribas B Pension Growth Cl

(0.3185%)

since

2025/07/31

12.

Schroder Global Healthcare A Acc

(0.1544%)

since

2025/07/31

13.

Deka-Europa Nebenwerte CF

(0.0977%)

since

2025/03/31

14.

BNP Paribas B Pension Stability Cl

(0.0896%)

since

2025/07/31

15.

Pareturn GVC Gaesco Absolute Return U

(0.0799%)

since

2025/07/31

16.

Pareturn GVC Gaesco Euro SC Eqty Fd U

(0.0799%)

since

2025/07/31

17.

BlackRock Health Sciences

(0.0796%)

since

2024/12/31

18.

GVC Gaesco T.F.T. FI

(0.0666%)

since

2025/07/31

19.

BSO Euro Santé I

(0.0533%)

since

2025/08/31

20.

Fidelity Nasdaq Composite Index

(0.0496%)

since

2025/07/31

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

2025-12-31

EPS Estimate

-0.6255

Latest Release

Date

2025-09-30

EPS Actual

-0.63

EPS Estimate

-0.6832

EPS Difference

0.0532

Surprise Percent

7.7869%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Weak Deep Value(2)
Defensive
Highly Defensive(6.5)
Dividend
Weak Dividend Profile(1.5)
Economic Moat
Some Competitive Advantage(3.3)
GARP
Fair GARP(4)
Growth
Weak Growth Prospect(3)
Momentum
No Momentum(3)
Net Net
Not Undervalued (Net-Net)(1)
Quality
Low Quality Business(2)
Value
Overpriced(3)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.